UNSPSC 51131818: Batroxobin

This classification denotes a protease inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 47RYF40GA9. European Medicines Agency schedules Batroxobin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00675MIG. The term BATROXOBIN is an International Non-Proprietary Name (see WHO INN reference publication, Volume 27, No. 10 1973, List 13.). World Health Organization schedules camostat in its Anatomical Therapeutic Chemical (ATC) Classification.

UNSPSC 51131818 Batroxobin is a Commodity code that captures a single pharmaceutical product — a serine protease derived from venom used clinically as a hemostatic agent. State and local governments procure batroxobin primarily through health and safety equipment solicitations cast at the broader law enforcement and public safety level, though the product itself is a pharmaceutical input rather than a police or tactical good. The issuing bodies under this code include cooperative purchasing vehicles (such as Sourcewell, a Minnesota local government unit and service cooperative) that aggregate demand across multiple jurisdictions — counties, municipalities, school districts, tribal governments, and nonprofit organizations — to establish framework agreements available to thousands of public entities nationwide.

The most recent and only visible opportunity under this code is Sourcewell RFP #061626, posted May 12, 2026 with a response deadline of June 16, 2026 at 3:30 p.m. Central Time, which solicits Law Enforcement Equipment broadly on behalf of participating entities including Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County in Washington, along with public entities throughout the United States and Canada. The solicitation does not itemize batroxobin or other specific pharmaceuticals by name; vendors must access full documentation through the Sourcewell Procurement Portal to determine whether batroxobin is listed as a required or optional line item. The cooperative structure allows selected vendors to supply equipment and materials (potentially including batroxobin) to a large cross-sector customer base. No specific award values, set-asides, or incumbent vendors are disclosed in the available documentation. Geographic activity is concentrated in Washington state and Minnesota (Sourcewell's home jurisdiction), with the cooperative structure extending participation nationwide.